TANDEM DIABETES CARE INC 10-K

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. Market Information Our common stock began trading on the Nasdaq Global Market on November 14, 2013 under the symbol “TNDM.” Prior to such time, there was no public market for our common stock. The following table sets forth the high and low intraday sales prices per share of our common stock as reported on the Nasdaq Global Market for the period indicated. Price Range High Low Year Ended December 31, 2021 First Quarter $ 105.00 $ 77.77 Second Quarter $ 100.80 $ 76.19 Third Quarter $ 130.73 $ 92.17 Fourth Quarter $ 155.86 $ 116.21 Year Ended December 31, 2020 First Quarter $ 91.65 $ 43.69 Second Quarter $ 99.33 $ 59.24 Third Quarter $ 116.89 $ 91.93 Fourth Quarter $ 123.74 $ 84.56 Holders of Record As of February 17, 2022, there were approximately 42 holders of record of our common stock. The actual number of common stockholders is greater than the number of record holders, and includes stockholders who are beneficial owners, but whose shares are held in street name by brokers and other nominees. This number of holders of record also does not include stockholders whose shares may be held in trust by other entities. Securities Authorized for Issuance under Equity Compensation Plans Information about our equity compensation plans, as set forth in this Annual Report under the caption “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters” in Part III, Item 12, is incorporated herein by reference. Unregistered Sales of Equity Securities None. Repurchases of Equity Securities We did not repurchase any of our equity securities during the years ended December 31, 2021 and 2020. Item 6. [Reserved]